ClinicalTrials.Veeva

Menu

Study of Arterial Recanalization of the Central Retinal Artery Occlusions (RECANAL)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Central Retinal Artery Occlusion

Study type

Observational

Funder types

NETWORK

Identifiers

NCT03049514
MOA_2016_22

Details and patient eligibility

About

Central retinal artery occlusions (CRAO) are the equivalent of an ischemic stroke (IS) at the retinal level. They share the same risk factors and common pathology. Their incidence is lower (8.5 / 100,000) and the functional prognosis is unfavorable in 80% of cases with visual acuity (VA) <1/10. The diagnosis of an CRAO is clinically based on the sudden occurrence of a decrease in deep visual acuity with fundamentally signs of reactive ischemia. There is no data on early retinal arterial recanalization after CRAO, nor on the relationship between early recanalization (spontaneous or post-thrombolysis) and visual prognosis.

Enrollment

80 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Central Retinal Artery Occlusion ≤ 24 hours

Exclusion criteria

  • Retinal Dynamic angiography not performed within 48 hours of onset of symptoms
  • Occlusion of a branch of the central retinal artery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems